๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial

โœ Scribed by G. T. EVERSON; M. L. SHIFFMAN; T. R. MORGAN; J. C. HOEFS; R. K. STERLING; D. A. WAGNER; C. C. KULIG; T. M. CURTO; E. C. WRIGHT; THE HALT-C TRIAL GROUP

Book ID
108605270
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
445 KB
Volume
27
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evolution of hepatic steatosis in patien
Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
โœ Anna S. Lok; James E. Everhart; Raymond T. Chung; Hae-Young Kim; Gregory T. Ever ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 404 KB ๐Ÿ‘ 2 views

Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C (CHC) but there are no large longitudinal studies describing the progression of steatosis in CHC. We examined changes in steatosis on serial biopsies among CHC patients participating in the Hepatitis C Antiviral Lo

Prognostic value of Ishak fibrosis stage
Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial
โœ James E. Everhart; Elizabeth C. Wright; Zachary D. Goodman; Jules L. Dienstag; J ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 472 KB ๐Ÿ‘ 2 views

Studies of the prognostic value of Ishak fibrosis stage are lacking. We used multi-year follow-up of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial to determine whether individual Ishak fibrosis stages predicted clinical outcomes in patients with chronic hepatitis C.

Herbal product use by persons enrolled i
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
โœ Leonard B. Seeff; Teresa M. Curto; Gyongyi Szabo; Gregory T. Everson; Herbert L. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB ๐Ÿ‘ 2 views

Herbal products, used for centuries in Far Eastern countries, are gaining popularity in western countries. Surveys indicate that persons with chronic hepatitis C (CHC) often use herbals, especially silymarin (milk thistle extract), hoping to improve the modest response to antiviral therapy and reduc